Association of Procalcitonin Value and Bacterial Coinfections in Pediatric Patients With Viral Lower Respiratory Tract Infections Admitted to the Pediatric Intensive Care Unit
Authors:
- John J. KotulaJKJohn J. Kotula
- Wayne S. MooreWMWayne S. Moore
- Arun ChopraACArun Chopra
- Jeffrey J. CiesJCJeffrey J. Cies
- 1 January 2018
- journal article
- Published by The Pediatric Pharmacy Association in The Journal of Pediatric Pharmacology and Therapeutics
- Vol. 23 (6) , 466-472
Abstract
OBJECTIVE Our primary objective was to determine the utility of procalcitonin (PCT) in detection of bacterial coinfection in children < 5 years admitted to the pediatric intensive care unit with viral lower respiratory tract infection (LRTI). METHODS Electronic medical record review of children < 5 years admitted to the pediatric intensive care unit with a viral LRTI who also had at least 1 PCT concentration measurement. RESULTS Seventy-five patients were admitted to the intensive care unit and met the inclusion criteria for this investigation. The PCT threshold concentrations of 0.9, 1, 1.4, and 2 ng/mL were found to be statistically significant in determining the presence of a bacterial coinfection. The PCT concentration with the most utility was 1.4 ng/mL with sensitivity, specificity, positive and negative predictive values of 46%, 83%, 68%, and 76%, respectively. For patients with serial PCTs, the second PCT correctly influenced treatment decisions for 11 of 25 patients (44%). CONCLUSIONS A PCT value of 1.4 ng/mL determined the presence of a bacterial coinfection primarily owing to the high specificity and negative predictive value. Our data add evidence to the relatively high negative predictive value of PCT concentrations in identifying patients with bacterial coinfection, specifically in the case of viral LRTI. In addition, our preliminary data indicate serial PCT measurements may help further influence correct treatment decisions. Prospective, controlled studies are warranted to validate an appropriate PCT threshold concentration to help in identifying bacterial coinfection as well as to further explore the role of serial PCT values in determining the absence or presence of a bacterial coinfection.Keywords
This publication has 15 references indexed in Scilit:
- Viral bronchiolitisThe Lancet, 2017
- Value of Procalcitonin Measurement for Early Evidence of Severe Bacterial Infections in the Pediatric Intensive Care UnitThe Journal of Pediatrics, 2016
- Clinical Practice Guideline: The Diagnosis, Management, and Prevention of BronchiolitisPediatrics, 2014
- Hospitalizations for Severe Lower Respiratory Tract InfectionsPediatrics, 2014
- Procalcitonin Use in a Pediatric Intensive Care UnitThe Pediatric Infectious Disease Journal, 2014
- Procalcitonin to Predict Bacterial Coinfection in Infants With Acute BronchiolitisPediatric Emergency Care, 2014
- Trends in Bronchiolitis Hospitalizations in the United States, 2000–2009Pediatrics, 2013
- Incidence of bacterial coinfection with respiratory syncytial virus bronchopulmonary infection in pediatric inpatientsJournal of Infection and Chemotherapy, 2011
- Procalcitonin as a Marker of Severe Bacterial Infection in Children in the Emergency DepartmentPediatric Emergency Care, 2010
- Procalcitonin does discriminate between sepsis and systemic inflammatory response syndromeArchives of Disease in Childhood, 2005